Price FDA-approved Wegovy first. NovoCare charges $199 for two starter fills, then $349 a month, and covered insurance can bring it to $25.

| Way to pay | What you pay | Good to know | Checked |
|---|---|---|---|
| Way to pay Telehealth, month to month Injection | What you pay $79–$289 per month | Good to know Median $154 across 10 providers that name semaglutide next to a month-to-month price. One provider’s fall sale is $49. | Checked Sep 23, 2026 our provider data |
| Way to pay Telehealth, first month Injection | What you pay $79–$179 first month | Good to know Median $129 across 11 providers. Several raise the price in month two, for example $112 then $212 at Enhance.MD. | Checked Sep 23, 2026 our provider data |
| Way to pay Telehealth, prepaid plans Injection | What you pay $79–$212 per month | Good to know Median $124 a month on each provider’s longest plan, often paid upfront, such as $1,428 for 12 months at bmiMD. | Checked Sep 23, 2026 our provider data |
| Way to pay A year, month to month (median) Injection | What you pay $1,848 per year | Good to know 12 months at the $154 median, or $2,002 if the provider bills every 28 days. | Checked Sep 26, 2026 our cost analysis |
| Way to pay Wegovy (FDA-approved), NovoCare self-pay Pen | What you pay $199–$349 per month | Good to know New patients pay $199 for the first two fills at 0.25 and 0.5 mg, then $349. Wegovy prices and providers. | Checked Sep 25, 2026 novocare.com |
| Way to pay Wegovy, 12-month subscription Pen | What you pay $249 per month | Good to know Novo’s subscription through its telehealth partners, for 0.25 to 2.4 mg pens. | Checked Sep 25, 2026 Novo announcement |
| Way to pay Medicare Part D: GLP-1 Bridge PenPill | What you pay Up to $50 per month | Good to know Covers FDA-approved Wegovy for eligible Part D enrollees through December 31, 2027. Compounded drugs aren’t part of it. | Checked Sep 26, 2026 medicare.gov |
Compare the month-to-month price, not the first-month offer. And price FDA-approved Wegovy before you commit: it costs $349 a month at NovoCare after the intro offer, or $249 a month on a 12-month subscription through Novo’s telehealth partners.
We track 27 telehealth providers that offer compounded semaglutide. These 12 publish a semaglutide price or are ones we’ve reviewed, sorted by the lowest monthly price each one lists. Plan length matters: some of the lowest prices need 12 months paid upfront. See all providers side by side.
Checked: Oct 4, 2026
Checked: Oct 4, 2026
Checked: Oct 4, 2026
Checked: Oct 4, 2026
Checked: Oct 4, 2026
Checked: Oct 4, 2026
Checked: Oct 4, 2026
Checked: Oct 4, 2026
Checked: Oct 4, 2026
Checked: Oct 4, 2026
Checked: Oct 4, 2026
Checked: Oct 4, 2026
Price FDA-approved Wegovy first. NovoCare charges $199 for two starter fills, then $349 a month, and covered insurance can bring it to $25.
Compare month-to-month prices, not first-month offers. Some providers raise the price by 60% to 90% in month two.
On Medicare Part D? The GLP-1 Bridge covers Wegovy for up to $50 a month. Compounded drugs aren’t included.
Check who makes it. Ask for the compounding pharmacy’s name and license, and skip anyone who sells it without a prescription.
Prepay only if you’re sure. The lowest per-month prices often need 6 to 12 months paid upfront, and refunds are limited.
Be wary of “generic Wegovy” claims. There is no generic Wegovy, and the FDA has warned telehealth companies against that wording.
Compounded semaglutide is semaglutide mixed by a compounding pharmacy instead of made by Novo Nordisk. It’s usually a weekly injection drawn from a multi-dose vial, and telehealth companies sell it with a prescription from their own clinicians.
Compounded drugs are not FDA-approved. During the semaglutide shortage, pharmacies could make copies of Wegovy and Ozempic. Since the FDA declared the shortage over in February 2025, copies are allowed only in limited cases, and the FDA has sent warning letters to dozens of telehealth companies over how they market them. On April 30, 2026, it also proposed excluding semaglutide from the list of drugs outsourcing facilities can compound. A final decision is pending.
Dosing errors are the main safety problem the FDA flags: some patients have been hospitalized after measuring doses from multi-dose vials. If you use it, confirm your dose in milligrams and units with the pharmacy. Our FDA-approved vs. compounded GLP-1s guide explains the differences.

At the providers we track, month-to-month plans cost $79 to $289 a month, with a median of $154. Prepaid plans bring the median to $124 a month, and first-month offers have a median of $129. One provider runs a $49 fall sale. We checked these prices on September 22 and 23, 2026.
Usually, yes. The median month-to-month price, $154, is less than half of Wegovy’s $349 self-pay price. But Wegovy can cost as little as $25 with covered insurance, or up to $50 through the Medicare GLP-1 Bridge, and compounded drugs don’t qualify for either.
No. The FDA doesn’t review compounded drugs for safety, effectiveness or quality before they’re sold. As of May 31, 2026, it had received 990 adverse-event reports for compounded semaglutide.
Not outright. Since the shortage ended in February 2025, pharmacies can make copies of FDA-approved semaglutide only in limited cases, and a federal appeals court upheld the FDA’s decision on August 27, 2026. The FDA has also proposed keeping semaglutide off the list outsourcing facilities can compound from. What’s changing for compounded GLP-1s.
No. Compounded versions aren’t tested or approved the way Wegovy is, and doses come from multi-dose vials that are easy to mismeasure. The FDA has told telehealth companies not to call compounded drugs “generic” or “the same as” a brand-name drug.
Many providers advertise a lower first month. In our data, Enhance.MD charges $112 and then $212, and Found (cash, 1-month plan) charges $179 and then $289. Check the month-two price before you sign up.
Few providers bill insurance for it, and Novo’s savings offer and the Medicare Bridge don’t apply. Some providers accept HSA or FSA cards, including Eden, Embody and Trimi, per their sites.
It can carry more risk than FDA-approved semaglutide, because the FDA doesn’t check its quality before it’s sold and dosing errors with multi-dose vials have sent some patients to the hospital. Work with a licensed clinician, use a state-licensed pharmacy, and confirm your dose in milligrams and units.
No. It’s a prescription drug. Legitimate providers require a medical intake and a prescription from a licensed clinician, so skip any site that sells it without one.
Looking More GLP-1 Medications?
View the full catalogue of GLP-1 Medications
We pulled month-to-month, first-month and prepaid prices from each provider’s own pricing pages on September 22 and 23, 2026, counting only prices that name semaglutide. We read NovoCare, TrumpRx.gov and the FDA’s compounding pages on September 25 and 26, 2026. We don’t buy the drug or sign up for plans. Every card shows when we checked it, and we recheck prices every month. If a price has changed, tell us.
Every provider on this page is an affiliate partner, and we earn a commission when you sign up through our links. Commissions never change the order or what we write. How we make money and our editorial policy explain the rules we follow. We drafted this page with AI assistance and checked every number against its source.


